Insider · CIK 0001962344
Andrew Dahlem
Files at SYRA (Syra Health Corp). First filing -, latest -.
In brief
Andrew Dahlem files SEC Form 4 as director at SYRA (Syra Health Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew Dahlem has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | SYRA Syra Health Corp | AGrant or award Stock Optionsderivative | +9,102 | $0.00 | $0 | 20,683 | Jan 8, 2025 |
| Nov 14, 2024 | SYRA Syra Health Corp | AGrant or award Stock Optionsderivative | +11,581 | $0.00 | $0 | 11,581 | Nov 18, 2024 |
Questions about Andrew Dahlem
Answered from the filings on this page, as of the latest one.
Is Andrew Dahlem buying or selling?
Andrew Dahlem has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew Dahlem's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Dahlem has 0.
Where does Andrew Dahlem file Form 4?
Andrew Dahlem has filed Form 4 at SYRA (Syra Health Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.